Markus Cavalar

Head of Molecular Infection Diagnostics EUROArray Division at EUROIMMUN
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
DE

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Germany
    • Biotechnology Research
    • 200 - 300 Employee
    • Head of Molecular Infection Diagnostics EUROArray Division
      • Aug 2020 - Present

      The EUROIMMUN AG is a world leader in the field of Medical Diagnostics. The areas of expertise are supported by a strong scientific team committed to improving healthcare by delivering innovative, clinically relevant diagnostic assays. These assays aid in the diagnosis of autoimmune and infectious diseases. Worldwide, EUROIMMUN offers one of the most extensive test menus in a variety of technology platforms used in over 6,000 laboratories. At present EUROIMMUN has 3700 employees, subsidiaries can be found in 15 countries worldwide. As of December 2017, the US American company PerkinElmer, Inc. holds the majority of the EUROIMMUN shares. PerkinElmer is an international leader in the area of medical and biotechnology with 11.400 employees worldwide. With innovative detection and imaging techniques and IT systems, it provides comprehensive expertise in diagnostics, medical research and environmental and food analytics. PerkinElmer, Inc. is a component of the S&P 500 Index.Activities and responsibilitieso Leadership of the division molecular infection diagnostics with 23 employees and a revenue of 5 Mio€ in 2021o R&D of test systems for the direct detection of virus, bacteria, parasite and fungi and their resistanceso Approval of medical device according to IVDR, MDSAP and FDAo Head of productiono Coordination of joint research projects with industrial and academic partnerso Evaluation of new methods, technologies and approaches of researcho Evaluation of Mergers & Acquisitionso Education of staff, trainees and customerso Expert support and supervision of external partner, sales representatives, customer, molecular pharmacology CROs and academic groupso Responsible for common MDx sales projects between the EUROIMMUN and PKI sales structures

    • Head of molecular infection diagnostics
      • Oct 2010 - Apr 2022

  • Grünenthal GmbH, Aachen
    • Kreisfreie Stadt Aachen und Umgebung, Deutschland
    • Lab manager and project leader
      • Jul 2005 - Oct 2010

      The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany. Grünenthal is specialized in the field of pain therapy and tread trend-setting paths. The Grünenthal Group has affiliates in 26 countries worldwide. Grünenthal products are sold in more than 155 countries. Today, approx. 4,400 employees are working for the Grünenthal Group worldwide. In 2012, Grünenthal achieved revenues of € 973 mn. Activities and responsibilities o Planning, establishment and implementation of molecular biological and biochemical analysis as well as functional cellular assays o Direction of a research project with an interdisciplinary project team o Evaluation of new methods, technologies and approaches of research o Research and presentation of the scientific background of actual and possible new projects o Project work as molecular pharmacology expert o Expert support and supervision of external partner, molecular pharmacology CROs and academic groups

    • Sales Representative
      • May 2005 - Jun 2005

      QIAGEN's position as the market leader for sample and assay technologies is based on more than 25 years of experience. Qiagen sell these products to academic research markets, to leading pharmaceutical and biotechnology companies, to molecular diagnostics laboratories as well as to customers in applied testing markets. Qiagen employs more than 2,600 people in over 40 locations worldwide. Activities and responsibilities o Sales and Marketing o Market analysis QIAGEN's position as the market leader for sample and assay technologies is based on more than 25 years of experience. Qiagen sell these products to academic research markets, to leading pharmaceutical and biotechnology companies, to molecular diagnostics laboratories as well as to customers in applied testing markets. Qiagen employs more than 2,600 people in over 40 locations worldwide. Activities and responsibilities o Sales and Marketing o Market analysis

Education

  • RWTH Aachen University
    Doktor (Ph.D.), Molecular biology
    2002 - 2005
  • RWTH Aachen
    Diplom Biologe, Biologie, allgemein
    1995 - 2001

Community

You need to have a working account to view this content. Click here to join now